August 6, 2021 – Far UV was highlighted as the 2nd fastest growing company in the Kansas City Business Journal’s Fast 50, with a 2 year average annual revenue growth rate of 2,913%
Headquarters
Latest News
- Far UV Continues to Help the ImmunocompromisedDecember 6, 2023 - 10:11 am
The use of this technology is not intended to take the place of reasonable precautions to prevent the transmission of pathogens. It is important to comply with all applicable public health laws and guidelines issued by federal, state, and local governments and health authorities as well as official guidance published by the Centers for Disease Control and Prevention (CDC), including but not limited to social distancing, face masks, vaccines, hand hygiene, and cough etiquette.
*All references to “disinfection” are referring generally to reduction of bioburden and are not intended to refer to any specific definition of the term as may be used for other purposes by the U.S. Food and Drug Administration or the U.S. Environmental Protection Agency. The disinfection technology as incorporated in Far UV Technologies products is not intended for use in the cure, mitigation or prevention of disease and is not certified or approved for use as or for the disinfection of medical devices by the FDA. Bioburden reduction is a function of fixture run time, distance to the UV light source, air flow, room size, shadow areas and/or other factors, and the level of reduction will vary within a specific space.